StockData

Cartesian Therapeutics, Inc. (RNAC) stock

RNACNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 1/30
$6.08−0.27 (-4.25%)

Close on Nov 16, 2026Market cap $183.95MP/E –Yield –

Cartesian Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Cartesian Therapeutics's market cap was $206.96M on Nov 10, 2026, against $194.77M a year earlier. Over the last 5 years it ranged from $89.91M to $485.46M, with a median of $209.05M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 10, 2026$206.96M+10.4%
2025Dec 31, 2025$187.49M-56.2%
2024Dec 31, 2024$427.99M+301.1%
2023Dec 29, 2023$106.69M-38.3%
2022Dec 30, 2022$172.92M-54.1%
2021Dec 31, 2021$376.35M+15.8%
2020Dec 31, 2020$324.93M+183.3%
2019Dec 31, 2019$114.71M+92.5%
2018Dec 31, 2018$59.57M-72.5%
2017Dec 29, 2017$217.00M-30.4%
2016Dec 30, 2016$311.93M–

More Cartesian Therapeutics figures

See a number that looks wrong?